Showing results (771-780 of 7,742) with videos related to

Sort By:
Pageof 775
Pharmacological Research|August 22, 2020
Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancersMohammad Hossein Pourhanifeh, Massoud Vosough, Maryam Mahjoubin-Tehran, et al.
Pharmacological Research|August 7, 2020
The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: A meta-analysis of randomized controlled trialsWei Xia, Nie Tang, Hamed Kord-Varkaneh, et al.
Pharmacological Research|August 8, 2020
Relevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditionsChristine Huynh, Jasper Dingemanse, Henriette E Meyer Zu Schwabedissen, et al.
Pharmacological Research|April 15, 2023
NIR-responsive molybdenum (Mo)-based nanoclusters enhance ROS scavenging for osteoarthritis therapyGuang Shi, Hailong Jiang, Fan Yang, et al.
Pharmacological Research|April 6, 2023
Echinatin inhibits the growth and metastasis of human osteosarcoma cells through Wnt/β-catenin and p38 signaling pathwaysQiuping Lu, Huakun Huang, Xiaoxuan Wang, et al.
Pharmacological Research|April 6, 2023
LKB1 signaling and patient survival outcomes in hepatocellular carcinomaKhoa Nguyen, Katherine Hebert, Emily McConnell, et al.
Pharmacological Research|March 28, 2021
Direct Keap1-kelch inhibitors as potential drug candidates for oxidative stress-orchestrated diseases: A review on In silico perspectiveIbrahim Damilare Boyenle, Ukachi Chiamaka Divine, Rofiat Adeyemi, et al.
Pharmacological Research|March 29, 2021
Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanismsPaulo Michel Pinheiro Ferreira, Rayran Walter Ramos de Sousa, José Roberto de Oliveira Ferreira, et al.
Pharmacological Research|March 30, 2021
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic developmentVincenzo Lionetti, Sveva Bollini, Raffaele Coppini, et al.
Pharmacological Research|April 8, 2015
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized studyGianluca Campo, Rita Pavasini, Simone Biscaglia, et al.
Pageof 775